Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease affecting nerve cells in the brain and spinal cord. Despite its devastating impact, recent advances in drug development are offering new hope for patients. The amyotrophic lateral sclerosis market is evolving, with numerous candidates in the amyotrophic lateral sclerosis pipeline showing significant promise....